scispace - formally typeset
Journal ArticleDOI

Platelets, inflammation and tissue regeneration

Alan T. Nurden
- 11 Apr 2011 - 
- Vol. 105
Reads0
Chats0
TLDR
They are major players in atherosclerosis and related diseases, pathologies of the central nervous system (Alzheimers disease, multiple sclerosis), cancer and tumour growth, and participate in other tissue-related acquired pathologies such as skin diseases and allergy, rheumatoid arthritis, liver disease; while, paradoxically, autologous platelet-rich plasma and platelet releasate are being used as an aid to promote tissue repair and cellular growth.
Abstract
Blood platelets have long been recognised to bring about primary haemostasis with deficiencies in platelet production and function manifesting in bleeding while upregulated function favourises arterial thrombosis. Yet increasing evidence indicates that platelets fulfil a much wider role in health and disease. First, they store and release a wide range of biologically active substances including the panoply of growth factors, chemokines and cytokines released from a-granules. Membrane budding gives rise to microparticles (MPs), another active participant within the blood stream. Platelets are essential for the innate immune response and combat infection (viruses, bacteria, micro-organisms). They help maintain and modulate inflammation and are a major source of pro-inflammatory molecules (e.g. P-selectin, tissue factor, CD40L, metalloproteinases). As well as promoting coagulation, they are active in fibrinolysis; wound healing, angiogenesis and bone formation as well as in maternal tissue and foetal vascular remodelling. Activated platelets and MPs intervene in the propagation of major diseases. They are major players in atherosclerosis and related diseases, pathologies of the central nervous system (Alzheimers disease, multiple sclerosis), cancer and tumour growth. They participate in other tissue-related acquired pathologies such as skin diseases and allergy, rheumatoid arthritis, liver disease; while, paradoxically, autologous platelet-rich plasma and platelet releasate are being used as an aid to promote tissue repair and cellular growth. The above mentioned roles of platelets are now discussed.

read more

Citations
More filters
Journal ArticleDOI

Saccular intracranial aneurysm: pathology and mechanisms

TL;DR: The aberrant flow conditions caused by sIA geometry are the likely cause of the endothelial dysfunction, which results in accumulation of cytotoxic and pro-inflammatory substances into the sIA wall, as well as thrombus formation.
Journal ArticleDOI

Platelet-rich plasma for managing pain and inflammation in osteoarthritis

TL;DR: Understanding PRP in molecular terms could help to exploit its therapeutic potential, and aid the development of novel treatments and tissue-engineering approaches, for the different stages of joint degeneration.
Journal ArticleDOI

Shared and distinct mechanisms of fibrosis

TL;DR: A number of core pathways and mechanisms of fibrosis, outlined in this Review, are shared across different tissues and might therefore present targets for general antifibrotic strategies and might enable the development of general antIFIBrotic compounds that are effective across different disease entities and organs.
Journal ArticleDOI

Platelets as Cellular Effectors of Inflammation in Vascular Diseases

TL;DR: Recently identified inflammatory and immune activities provide insights into the biology of these versatile blood cells that are directly relevant to human vascular diseases.
Journal ArticleDOI

Platelet-derived HMGB1 is a critical mediator of thrombosis.

TL;DR: Platelet-derived HMGB1 is established as an important mediator of thrombosis and a HMGB 1-driven link between MyD88 and GC/cGKI in platelets is identified and suggested a potential therapeutic target for patients sustaining trauma and other inflammatory disorders associated with abnormal coagulation.
References
More filters
Journal ArticleDOI

Efficacy and safety of recombinant human activated protein C for severe sepsis.

TL;DR: This phase 3 trial assessed whether treatment with drotrecogin alfa activated reduced the rate of death from any cause among patients with severe sepsis.
Journal ArticleDOI

Angiogenesis in health and disease.

TL;DR: Molecular insights into the formation of new blood vessels are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.
Journal ArticleDOI

The immune response in atherosclerosis: a double-edged sword

TL;DR: This Review focuses on the role of immune mechanisms in the formation and activation of atherosclerotic plaques, and also includes a discussion of the use of inflammatory markers for predicting cardiovascular events.
Journal ArticleDOI

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

TL;DR: It is proposed that platelet TLR4 is a threshold switch for this new bacterial trapping mechanism in severe sepsis, where NETs have the greatest capacity for bacterial trapping.
Journal ArticleDOI

Membrane Fusion: Grappling with SNARE and SM Proteins

TL;DR: The two universally required components of the intracellular membrane fusion machinery, SNARE and SM (Sec1/Munc18-like) proteins, play complementary roles in fusion and are spectacularly apparent in the exquisite speed and precision of synaptic exocytosis.
Related Papers (5)